CanniMed Therapeutics Inc.’s Latest Attempt to Stifle the Aurora Cannabis Inc. Takeover Bid

Can Aurora Cannabis Inc. (TSX:ACB) thwart CanniMed Therapeutics Inc.’s (TSX:CMED) own acquisition plans? Let’s take a look at the latest.

| More on:

Marijuana stocks have been popular news all year, and one of the hottest stocks has been Aurora Cannabis Inc. (TSX:ACB). The company has been making news recently for its attempt to take over rival CanniMed Therapeutics Inc. (TSX:CMED). CanniMed was not thrilled with the bid and has already tried to thwart its investors from accepting the all-stock deal. (The bid was previously discussed in this recent Fool article by David Jagielski.) What’s the latest news with the deal? Let’s take a look.

Aurora Cannabis tries to stop CanniMed’s own acquisition

CanniMed previously announced its plans to buy Newstrike Resources Ltd. (TSXV:HIP). Newstrike is a smaller player based in Brantford, Ontario. The company is a licensed producer of medical marijuana.

Aurora Cannabis spoke about the deal on December 18, claiming it is a “terrible deal” for CanniMed’s stockholders. Aurora stated it plans to issue an official circular to all shareholders stating their disagreement with the plan. Aurora’s goal is to convince CanniMed shareholders to vote down the planned acquisition. Aurora claims Newstrike is failing and has no clients or revenues. Looking at Newstrike’s most recent financial statements listed on sedar.ca, Aurora is right. There is no revenue listed, and the company is reporting a net loss, similar to last year’s filing.

The Ontario Securities Commission (OSC) has a hearing scheduled to listen to CanniMed’s request to intervene in their hostile takeover on December 20. It will be interesting to see what comes out of the hearing. CanniMed is also trying to have Aurora’s planned takeover listed as an insider bid by both the OSC and Saskatchewan’s securities regulator. (CanniMed is based in Saskatoon.)

How Aurora Cannabis looks otherwise

Aurora’s stock price has been on a tear since the beginning of November, moving from just under $3 per share to the $7-per-share range. The stock reported positive earnings per share of $0.01 cent for the quarter ending September 30, which would be the first positive earnings the company has reported. Revenues have been below expenses. The stock has a high price-to-book ratio of 10.94 and a non-existent P/E ratio. The stock price increase has given it a one-year return in the triple digits, though. Here’s more recent analysis on the stock by Fool contributor Ambrose O’Callaghan.

Bottom line

Even without the uncertainty of the takeover bid, marijuana stocks are still speculative investments. There is still so much unknown about the retail marijuana market in Canada, so it’s hard to say if the stock prices of marijuana companies will continue to rise, or if they’ll come crashing back down to earth instead.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Susan Portelance has no position in any stocks mentioned.

More on Investing

a man relaxes with his feet on a pile of books
Dividend Stocks

CPP Pensioners: Watch for These Important Updates

The CPP is an excellent tool for retirees, but be sure to stay on top of important updates like these.

Read more »

Technology
Dividend Stocks

TFSA Investors: 3 Dividend Stocks I’d Buy and Hold Forever

These TSX dividend stocks are likely to help TFSA investors earn steady and growing passive income for decades.

Read more »

money goes up and down in balance
Investing

Unveiled: 2 Must-Watch Stocks for Your TFSA Before 2025

Value-conscious TFSA investors should consider Bank of Nova Scotia (TSX:BNS) and another great dividend pick.

Read more »

four people hold happy emoji masks
Dividend Stocks

Love Dividend Growth? Check Out These 2 Income-Boosting Stocks

National Bank of Canada (TSX:NA) and another Canadian dividend-growth stock are looking like a bargain going into December 2024.

Read more »

An investor uses a tablet
Dividend Stocks

A Dividend Giant I’d Buy Over Enbridge Stock Right Now

Enbridge stock may seem like the best of the best in terms of dividends, but honestly this one is far…

Read more »

how to save money
Dividend Stocks

Got $1,000? The 3 Best Canadian Stocks to Buy Right Now

If you're looking for some cash flow from your $1,000 investment, these are the ideal investments to make.

Read more »

Data center servers IT workers
Tech Stocks

Better Buy: Shopify Stock or Constellation Software?

Let's dive into whether Shopify (TSX:SHOP) or Constellation Software (TSX:CSU) are the better options for growth investors in this current…

Read more »

Electricity transmission towers with orange glowing wires against night sky
Investing

Fortis Rose 11% in 90 Days, and it’s Still a Good Stock to Buy Now

Here's why Fortis (TSX:FTS) is among the top dividend stocks I think long-term investors want to own in this current…

Read more »